This communication is in furtherance to the outcome of Board Meeting held on November 27,2025 approving the Rights Issue of fully paid-up Equity shares of face value of Rs.10/- each up tothe extent of Rs.3000 Lakhs to eligible Equity Shareholders of the Company.We would like to inform you that a meeting of the Rights Issue Committee of the Board isscheduled to be held on Wednesday, December 3, 2025 to consider:Issue Price, Entitlement Ratio, Record date, Issue open and closure dates, and other modalitiesrelated to Rights Issue, subject to the receipt of In-principle approval from BSE and NSE, wherethe securities of the Company are listed or such other regulatory authorities as may be required.
VINEETLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vineet Laboratories has received board approval for a Rights Issue of fully paid-up equity shares with a face value of Rs. 10 each, sized up to Rs. 30 crore (Rs. 3,000 lakhs). The offer will be made to existing eligible equity shareholders of the company. A Rights Issue Committee meeting is scheduled for December 3, 2025 to finalise key terms such as the issue price, entitlement ratio, record date, and issue opening and closing dates. The rights issue is subject to receiving in-principle approval from BSE and NSE where the company's shares are listed.
Existing shareholders will get a chance to subscribe to additional shares and maintain their ownership stake, but those who do not participate may see their holding diluted. The final pricing and entitlement ratio will be known after the December 3 committee meeting, which will be the key trigger for the stock.